MYC and sarcoma: Here, inclusion of KrasG12D generated a tumor morphology closer to sarcoma (Fig. 6D), while AKT and c-Myc bearing tumors closely resembled the more clinically-relevant carcinoma (Fig. 6B) [50–52].